Grégoire Courtine
Founder presso ONWARD MEDICAL N.V.
Patrimonio netto: 4 M $ in data 31/03/2024
Profilo
Grégoire Courtine is the founder of Onward Medical SA and Onward Medical NV, both founded in 2014.
He holds the title of Director, Chief Scientific & Marketing Officer at Onward Medical SA and Director & Chief Scientific Officer at Onward Medical NV.
Currently, he holds the position of Director at Centre Hospitalier Universitaire Vaudois and Professor at Swiss Federal Institute of Technology.
He previously worked as Director at NeuroRestore.
Dr. Courtine received a doctorate degree from the University of Pavia.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
ONWARD MEDICAL N.V.
2.27% | 25/03/2024 | 786 072 ( 2.27% ) | 4 M $ | 31/03/2024 |
Posizioni attive di Grégoire Courtine
Società | Posizione | Inizio |
---|---|---|
ONWARD MEDICAL N.V. | Founder | 01/12/2014 |
Onward Medical SA
Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | Founder | 01/12/2014 |
Swiss Federal Institute of Technology | Corporate Officer/Principal | - |
Centre Hospitalier Universitaire Vaudois
Centre Hospitalier Universitaire Vaudois Hospital/Nursing ManagementHealth Services Centre Hospitalier Universitaire Vaudois is a university hospital located in Lausanne, CH. The SwitzerlandUV is also a renowned center of medical education and research, collaborating with the Faculty of Biology and Medicine of the University of Lausanne and the Swiss Federal Institute of Technology in Lausanne (EPFL). It has 16 clinical and medico-technical departments and is known for its academic achievements in healthcare, research, and teaching. The vast campus in the lake region is home to these institutions. The CEO of the Swiss company is Nicolas Demartines. | Director/Board Member | - |
Precedenti posizioni note di Grégoire Courtine
Società | Posizione | Fine |
---|---|---|
NeuroRestore
NeuroRestore Pharmaceuticals: MajorHealth Technology NeuroRestore is a platform of symptom-relieving drug candidates for disease states in which cognitive ability is impaired, such as Alzheimer's disease, sleep apnea, traumatic brain injury, and Parkinson's disease. NeuroRestore is based in Lausanne, Switzerland. The Swiss company stimulates specific signaling pathways in the central nervous system known as neurotrophins, which play a crucial role in the function of nerve cells. The most well-known neurotrophins are NGF (nerve growth factor) and BDNF (brain-derived neurotrophic factor). NeuroRestore's drug candidates enhance communication between nerve cells and improve cognitive ability. The private company's leading drug candidate, ACD856, has recently completed clinical phase I studies and demonstrated positive effects. | Director/Board Member | - |
Formazione di Grégoire Courtine
University of Pavia | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ONWARD MEDICAL N.V. | Commercial Services |
Aziende private | 3 |
---|---|
Centre Hospitalier Universitaire Vaudois
Centre Hospitalier Universitaire Vaudois Hospital/Nursing ManagementHealth Services Centre Hospitalier Universitaire Vaudois is a university hospital located in Lausanne, CH. The SwitzerlandUV is also a renowned center of medical education and research, collaborating with the Faculty of Biology and Medicine of the University of Lausanne and the Swiss Federal Institute of Technology in Lausanne (EPFL). It has 16 clinical and medico-technical departments and is known for its academic achievements in healthcare, research, and teaching. The vast campus in the lake region is home to these institutions. The CEO of the Swiss company is Nicolas Demartines. | Health Services |
Onward Medical SA
Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | Health Technology |
NeuroRestore
NeuroRestore Pharmaceuticals: MajorHealth Technology NeuroRestore is a platform of symptom-relieving drug candidates for disease states in which cognitive ability is impaired, such as Alzheimer's disease, sleep apnea, traumatic brain injury, and Parkinson's disease. NeuroRestore is based in Lausanne, Switzerland. The Swiss company stimulates specific signaling pathways in the central nervous system known as neurotrophins, which play a crucial role in the function of nerve cells. The most well-known neurotrophins are NGF (nerve growth factor) and BDNF (brain-derived neurotrophic factor). NeuroRestore's drug candidates enhance communication between nerve cells and improve cognitive ability. The private company's leading drug candidate, ACD856, has recently completed clinical phase I studies and demonstrated positive effects. | Health Technology |
- Borsa valori
- Insiders
- Grégoire Courtine